SeeFundsee funds clearly 🔍
Saved Sign in

IHE — iShares U.S. Pharmaceuticals ETF

Data as of 2026-09-21 · US · Sectors · window 2016-09-21 → 2026-09-21 (10.0 years) · returns assume dividends reinvested, net of fund fees · Market Data from Tiingo.com

What the history says

IHE
Total return+131.8%
Annualised (CAGR)+8.8%
Volatility (annualised)+15.5%
Sharpe (rf = 0)0.57
Deepest drawdown-29.6%
Drawdown peak → trough2018-08-31 → 2020-03-23

Over the 10.0 years to 2026-09-21 the fund returned +131.8% in total (+8.8% a year), with a deepest drawdown of -29.6% from 2018-08-31 to 2020-03-23. Its worst calendar year was 2016 (-7.8%), its best 2025 (+31.7%).

Every calendar year

Calendar-year returns (net of fees, dividends reinvested)
YearIHE
2026+21.3%
2025+31.7%
2024+8.1%
2023+1.1%
2022-4.9%
2021+13.1%
2020+13.7%
2019+15.5%
2018-7.8%
2017+10.7%
2016-7.8%

What this page does not say

It does not say IHE is a good or bad fund, and it is not a forecast. Returns above are history: they already include dividends and already exclude the fund's own fees. A drawdown of -29.6% means an investor who bought at the peak would have watched that much value disappear before it recovered — how long that takes is the part most tables leave out.

Run your own window, add fees or a second fund: open IHE in the tool. History is shown as history, never sold as a forecast.

More in US · Sectors: COPX · AIRR · AMLP · all fund pages